Assessment of chemical-induced local irritation and inflammation in organotypic lung tissue model : precision-cut lung slices (PCLS) by Wang-Lauenstein, Lan
  
Assessment of chemical-induced local irritation and 
inflammation in organotypic lung tissue model - 
Precision-cut lung slices (PCLS) 
 
 
 
Von der Naturwissenschaftlichen Fakultät der Gottfried Wilhelm  
Leibniz Universität Hannover 
 
 
zur Erlangung des Grades 
Doktorin der Naturwissenschaften  
Dr. rer. nat. 
 
genehmigte Dissertation 
 
 
von 
 
Diplom-Biologin Lan Wang-Lauenstein 
geboren am 19.04.1980 in Tianjin, China 
-2017- 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referent: Prof. Dr. rer. nat. Armin Braun 
Korreferent: Prof. Dr. rer. nat. Georg Herrler 
Tag der Promotion: 22.12.2016  
Table of contents
Zusammenfassung ............................................................................................................. I 
Abstract ............................................................................................................................. II 
Preamble ......................................................................................................................... III 
1 Introduction ........................................................................................................... 1 
1.1 Immune mechanisms of airway responses to injury ......................................... 1 
1.2 Inhalation of toxicants can induce respiratory toxicity .................................... 2 
1.3 Pathogenesis of asthma and occupational asthma ............................................ 4 
1.3.1 Mechanisms of immunologically mediated asthma ................................. 4 
1.3.2 Mechanisms of non-immunologically mediated asthma .......................... 6 
1.4 Test methods for the identification of different sensitizers .............................. 7 
1.4.1 In vivo test methods for the identification of respiratory and contact 
sensitizers .............................................................................................................. 7 
1.4.2 In vitro, in chemico, and in silico alternative test methods for the 
identification of sensitizers.................................................................................... 8 
1.5 PCLS reflect the natural immunological responses 
 of the intact organ ...................................................................................................... 10 
2 Hypothesis ........................................................................................................... 12 
3 Assessment of immunotoxicity induced by chemicals in human precision-cut 
lung slices (PCLS) .......................................................................................................... 13 
4 Prevalidation of the ex-vivo model PCLS for prediction of respiratory toxicity 30 
5 General discussion............................................................................................... 58 
5.1 Chemical-induced toxicity in the development of acute lung injury.............. 58 
5.1.1 Inhalation of toxicants leading pulmonary epithelial injury ................... 58 
5.1.2 Assessment of toxic features of acute lung injury in live lung sections . 59 
5.2 Chemical-induced toxicity in the development of non-immunologically 
mediated occupational asthma .................................................................................... 62 
5.2.1 Measurement of cytokines for the assessment of chemical-induced 
inflammation in PCLS model .............................................................................. 62 
5.2.2 Live lung sections for the risk assessment of non-immunologically 
mediated occupational asthma ............................................................................ 65 
5.3 Predictivity of the ex vivo model PCLS for respiratory toxicology ............... 66 
5.3.1 Reproducibility of PCLS in rat ............................................................... 66 
5.3.2 Correlation of PCLS to published in vitro models ................................. 67 
5.3.3 Assessment of in vivo relevance of PCLS model .................................. 68 
6 Outlook ................................................................................................................ 69 
7 List of abbreviations ............................................................................................ 70 
8 Appendix I: List of publications.......................................................................... 72 
Table of contents 
 
9 Appendix II: Curriculum Vitae ........................................................................... 73 
10 Appendix III: First author´s contribution to the papers of this thesis ................. 74 
11 Appendix IV: Acknowledgements ...................................................................... 75 
12 List of references ................................................................................................. 76 
 
 
Zusammenfassung 
I 
 
Zusammenfassung 
Das Ziel dieser Arbeit war die Analyse immuntoxischer Effekte bei Chemikalien-induzierter 
respiratorischer Irritation und Sensibilisierung in einem organotypischen Gewebekulturmodell 
aus Präzisionslungenschnitten (PCLS). Dafür wurden relevante LMW Chemikalien, darunter 
respiratorische Sensibilisatoren, Kontaktsensibilisatoren und nicht-sensibilisierende Reizstoffe, 
an PCLS getestet. 
EC50-Werte für die Chemikalien-induzierte Toxizität in humanen PCLS wurden mit EC50-
Werten aus in vitro Daten von THP-1 und NCTC Zelllinien, mit Hilfe derer sich verschiedene 
Aspekte von Monozyten und Epithelzellen darstellen lassen, korreliert. Weiterhin wurde eine 
signifikante Korrelation mit LD50-Werten aus in vivo Inhalationsstudien an Ratten ermittelt, die 
für in vivo Dosisfindungsstudien relevant ist. Zur Quantifizierung lokaler 
Entzündungsreaktionen wurde die Freisetzung relevanter Zytokine und Chemokine quantitativ 
erfasst. TNF-α und IL-1α Konzentrationen waren in humanen PCLS nach der Exposition mit 
den respiratorischen Sensibilisatoren Trimellithsäureanhydrid und Ammonium 
Hexachloroplatinat in subtoxischen Konzentrationen signifikant erhöht, während 
Kontaktsensibilisatoren und nicht-sensibilisierende Reizstoffe die Freisetzung dieser Zytokine 
nicht im gleichen Ausmaß induzierten. Die vorläufigen Ergebnisse zeigen die Eignung von 
PCLS als ex vivo Modell für die Untersuchung von Immunreaktionen. Dieses Modell kann für 
die Vorhersage von Chemikalien-induzierter Toxizität verwendet werden, ist allerdings 
aufgrund der Komplexität der Funktions- und Reaktions-Veränderungen von unter anderem z.B. 
dendritischen Zellen (DCs) und T-Zellen für ein einfaches Screening der Allergene ungeeignet. 
Um PCLS als ein geeignetes alternatives ex vivo Modell zur Reduktion der Tieranzahlen von 
inhalationstoxikologischen Untersuchungen zu bewerten haben drei unabhängige Laboratorien 
(Fraunhofer ITEM, BASF SE und der RWTH Aachen) parallel das toxische Potenzial von 20 
Chemikalien mittels PCLS bestimmt. Über 900 Dosis-Wirkungskurven wurden generiert und 
analysiert. Die ermittelten Log10[IC50 (µM)] Werte ergaben für alle Daten, die mittels WST-1 
und BCA-Tests erhoben wurden, die beste Interlabor-Konsistenz. Während sich durch WST-1 
und LDH toxische Wirkungen nach der Zugabe der meisten Substanzen darstellen ließen, 
konnten in mindestens einem der drei beteiligten Laboratorien signifikante Erhöhungen der 
extrinsischen IL-1α Konzentration mit respiratorischen Sensibilisatoren, nicht mit nicht-
sensibilisierenden Reizstoffen beobachtet werden. Die Reproduzierbarkeit unter den 
teilnehmenden Laboratorien zeigte hinreichend niedrige Variationen bei den Daten der WST-1 
und BCA Tests. Die Etablierung der PCLS als akutes Toxizitätsmodell wurde mit einem kleinen 
Datensatz erfolgreich durchgeführt und mit 20 verschiedenen Chemikalien verifiziert. 
Schlagworte: Präzisionslungenschnitte; respiratorische Toxizität; Vorhersagemodell
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Abstract 
The aim of these studies was to assess the immunotoxicity occurring in chemical-induced 
irritation and sensitization by using an organotypic tissue culture model precision-cut lung slices 
(PCLS). For that, LMW human health relevant chemicals, including respiratory sensitizers, 
contact sensitizers and non-sensitizing irritants were tested in PCLS. 
EC50 values from chemical-induced toxicity in human PCLS were correlated significantly on the 
one hand with in vitro data published for THP-1 and NCTC cell lines, which have different 
aspects of monocyte-derived cells and skin-derived epithelial cells, and on the other hand with 
LD50 values from in vivo rat inhalation studies, which could be interesting for in vivo dose-
finding studies. Local respiratory inflammation was quantified by measuring the production of 
cytokines and chemokines. TNF-α and IL-1α were increased significantly in human PCLS after 
exposure to the respiratory sensitizers trimellitic anhydride and ammonium hexachloroplatinate 
at subtoxic concentrations, while contact sensitizers and non-sensitizing irritants failed to induce 
the release of these cytokines to the same extent. The preliminary results show an ex vivo model 
for studying immunotoxicity responses which might be used for prediction of chemical-induced 
toxicity, but is far too complex for a simple screening of allergens based on functional and 
behavior changes of e.g. dendritic cells (DCs) and T-cells. 
In order to assess PCLS as a suitable alternative ex vivo approach to reduce animal numbers of 
inhalation toxicology, three independent laboratories (Fraunhofer ITEM, BASF SE and RWTH 
Aachen) have analyzed parallel toxic potential on PCLS exposed to 20 chemicals. More than 
900 dose-response curves have been fitted and analyzed. Log10[IC50 (µM)] obtained for all assay 
endpoints showed best inter-laboratory consistency for the data obtained by WST-1 and BCA 
assays. While WST-1 and LDH indicated toxic effects for majority of the substances, significant 
increases in extrinsic IL-1α could be observed in many respiratory sensitizers but not in non-
sensitizing irritants at one of the three participating laboratories at least. The reproducibility 
within the participating laboratories appeared to have acceptably low between-lab variations for 
WST-1 and BCA assay. The assessment of PCLS as an acute toxicity model was successfully 
established with a small training data set and verified by 20 different chemicals.  
Keywords: precision-cut lung slices; respiratory toxicity; prediction model 
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Preamble 
This doctoral thesis was prepared at the Fraunhofer Institute for Toxicology and 
Experimental Medicine (ITEM) in the Department of Pre-clinical Pharmacology and In 
Vitro Toxicology under the supervision of Prof. Dr. Armin Braun and Dr. Katherina 
Sewald. Human lung tissue for the preparation was obtained in cooperation with 
Klinikum Region Hannover. The prevalidation of the ex vivo model PCLS for the 
prediction of respiratory toxicology was conducted in three independent laboratories 
(Fraunhofer ITEM, BASF SE, RWTH Aachen). BfR was partner for scientific advice 
and efficient conduction of the project. Ex vivo experiments were performed to evaluate 
the potential of PCLS to reflect the immune responses described in occupational 
asthma. 
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1 Introduction 
This doctoral thesis describes the use of an alternative ex vivo model of precision-cut 
lung slices (PCLS) to implement local respiratory toxicity by assessing a broad variety 
of toxicological and immunological endpoints. Therefore, animal and human PCLS 
were exposed to LMW chemicals including well-known industry sensitizers and non-
sensitizing irritants. At the beginning of this study chemical-induced irritation and 
inflammation in the airway were tested by using cytotoxicity testing and the 
determination of cytokine patterns. After that chemical-induced irritation was 
prevalidated with a training set of twenty chemicals in three independent laboratories in 
order to reduce animal testing numbers of inhalation toxicology with regard to dose-
finding. 
 
1.1 Immune mechanisms of airway responses to injury 
The respiratory tract is daily exposed to 10.000 litres of inhaled air containing a wide 
variety of exogenous potentially harmful agents [Holt et al., 2008]. The inhaled agents 
can be either infectious like bacteria, fungi and viruses or non-infections like allergens 
and chemicals [Hammad et al., 2008]. In order to protect the body from inhaled agents, 
the respiratory immune system composes a complex network of interacting cells 
including inflammatory and structural cells in the airway tissue which play an effective 
host defense system against harmful inhaled irritants.  
The respiratory airway epithelium assemble the first line of defense against inhaled 
agents [Hammad et al., 2008]. Airway epithelial cells can for example express many 
pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) for a quick 
detection of pathogens and response to pathogen-associated molecular patterns 
(PAMPs). These are present in pathogens like gram-negative bacteria as 
lipopolysaccharides. PRRs are also present on cells like macrophages, dendritic cells 
(DCs), endothelial cells, mucosal epithelial cells, and lymphocytes. The activation of 
PRRs leads to NF- B activation, release of pro-inflammatory cytokines and chemokines 
such as tumor necrosis factor (TNF)-α, interleukin (IL)-1α and IL-8. The released 
cytokines and chemokines support on the one hand the inflammation in the airways and 
the contractility of airway smooth muscle cells [Adner et al., 2002; Berry et al., 2007], 
on the other hand the activation of for example DCs in both conducting airways and 
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lung parenchyma which coordinates the adaptive immune responses [Veres et al., 
2007].  
After the activation of DCs, they migrate to the draining lymph nodes and process 
antigen presentation to CD4+ or CD8+ T cells. These cells belong to the major T cell 
subsets that play a central role in immune system function. If the antigen presentation is 
mediated by MHC class II, it will be recognized by naive CD4+ T cells. Naive CD4+ T 
cells will be primed by the communication and differentiate into effector and memory 
cells. The phenotypes of effector CD4+ T cells can differ into various subsets like T 
helper cells (TH)1, TH2, TH17, and regulatory T cells (Treg) depending on the 
stimulation conditions [Chen et al., 2013] (Figure 1). T helper cells can activate B cells 
to differentiate into plasma cells and memory B cells which can produce high-affinity 
antibodies and circulate into tissues or mucosa to reach sites of local infection and 
render their effector role. The circulating antibodies could provide immediate protection 
against infections with the same antigen [Ron et al., 1981]. In this case, memory B cells 
are activated by the recall antigen resulting in a secondary response which provides high 
level of protection. All the interactions mentioned above are via soluble mediators for 
the crosstalk between structural cells, innate and adaptive immune cells to provide the 
local immunoregulation which eventually controlled immunological homeostasis in the 
airway [Bao et al., 2014].  
 
 
Figure 1: The phenotypes of effector CD4+ T cells after stimulation with different antigens. TH cells: T 
helper cells, Treg: regulatory T cells. 
 
1.2 Inhalation of toxicants can induce respiratory toxicity 
Inhalation of environmental and industrial chemical substances can cause respiratory 
toxicity. Damage may occur in the upper and lower airways including the nasal 
passages, pharynx, trachea, and bronchi [McKay, 2014]. Respiratory toxicity leads to a 
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variety of acute and chronic pulmonary diseases, including local irritation, pulmonary 
edema, acute respiratory dysfunction syndrome (ARDS), bronchitis, emphysema, 
asthma and cancer [McKay, 2014]. Most respiratory irritants are also toxic to the lung 
parenchyma if inhaled substances reach the deep lung in sufficient amount [Saric et al., 
2000]. However, many inhaled substances have also systemic toxic effects after being 
absorbed and passed through the lungs. Body responses to inhalation of toxicants 
include not only injury in the respiratory system but also blood and other organs such as 
spleen which can induce severe organ injury [Hayes et al., 2010]. Acute responses of 
lung to injury could also induce cell necrosis exposed to e.g. acidic or alkaline agents 
which can alter cell membrane permeability, and lead to cell death. 
A typical disease example of acute lung injury is the acute respiratory distress syndrome 
(ARDS), which is characterized by noncardiogenic pulmonary edema, severe 
hypoxemia and decreased lung compliance after exposure to high-dose inhalation of 
toxicants [McKay, 2014]. A common feature of acute lung injury and ARDS is 
increased alveolar membrane permeability followed by epithelial and endothelial 
disturbance and a diffuse inflammation in the pulmonary parenchyma. [Saguil et al., 
2012; Wang et al., 2008]. The onset of ARDS occurs within 12-72 hours after initial 
lung injury caused by exposure to direct or indirect respiratory toxicants which leads to 
activation and accumulation of neutrophils [Ware et al., 2000]. Consequently, released 
multiple pro-inflammatory cytokines such as IL-8, IL-1, TNF-α, released reactive 
oxygen species (ROS), and migration of large numbers of neutrophils across endothelial 
and type I pneumocyte surfaces lead to pulmonary edema, increased permeability, gaps 
in the alveolar epithelial cells, and necrosis of type I and II pneumocyte cells [Tsushima 
et al., 2009]. At the end, formation of fibrosis in pulmonary parenchyma, loss of 
surfactant, and decrease of pulmonary compliance accelerate severe respiratory failure 
[Meduri et al., 1998].  
Prolonged exposure to respiratory toxicants can cause structural damage in the lungs, 
resulting in chronic diseases such as pulmonary fibrosis, emphysema, and cancer 
[Goldkorn et al., 2013; Mulla et al., 2013]. Oxidative stress is the best understood 
pathophysiological component of airway diseases such as chronic obstructive 
pulmonary disease (COPD) [Kirkham et al., 2013]. Oxidative stress is derived from 
increased burden of inhaled oxidants like cigarette smoke, and from the increased 
amounts of ROS generated by inflammatory, immune and various structural cells of the 
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airways leading to specific loss of ciliated cells of the airway epithelium and of type I 
pneumocyte cells, and subsequently disturbance of the tight junction interface causing 
subepithelial and submucosal damage and further inflammatory response and 
bronchoconstriction [Tuder et al., 2012].  
Certain compounds, such as trimellitic anhydride, glutaraldehyde, and some metals like 
platinum can act not only as non-specific irritants in high concentrations, but can also 
induce allergic sensitization like asthma as well [Kimber et al., 2014]. 
 
1.3 Pathogenesis of asthma and occupational asthma 
1.3.1 Mechanisms of immunologically mediated asthma  
Asthma is a heterogeneous chronic inflammatory disease. Common asthma symptoms 
include recurrent attacks of shortness of breath, wheezing, chest tightness and coughing. 
It is characterized by reversible airflow obstruction, airway hyperresponsiveness, mucus 
hyersecretion, and airway remodeling [NHLBI Guideline, 2007]. Airway inflammation 
is elemental to asthma pathogenesis supported by the presence of inflammatory cells 
such as eosinophils, allergen-specific TH2 cells, immunoglobulin (Ig) E, and mast cells 
[Galli, 1997; Lane et al., 1996; Leckie et al., 2000; NHLBI Guideline, 2007].  
Asthma can be classified as atopic and non-atopic asthma. Although non-atopic asthma 
has a different clinical profile than atopic asthma, however, both diseases are 
determined by concerned immunopathological characters which are dominated by TH2 
cells and IgE [Kudo et al., 2013]. In non-atopic asthma bronchial hyperreactivity is 
mostly in response to stimuli such as cold air or exercise, whereas atopic asthma is 
induced by inhaled allergens such as pollen, house dust mites, or chemicals [Corren, 
2013]. In atopic asthma, T cells are mostly differentiated into TH2 cells with expression 
of TH2 type cytokines, such as IL-4, IL-5, and IL-13 which initiate sensitization and the 
subsequent immune responses to the specific allergen by accumulation and infiltration 
of eosinophils, mast cells, and recruitment TH2 cells and further recruitment of mast 
cells and eosinophils [Finiasz et al., 2011]. IgE production by B cells and recruitment of 
T cells during the late phase of allergic reactions causes a secondary immune response 
with high-affinity and antigen-specific antibodies that can act rather quickly if the same 
type of antigen appears in the future [Eckl-Dorna et al., 2013]. Additionally, 
chemokines such as eotaxin, IL-8, RANTES, MCP-1 are released to elevate the 
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migration of further immune cells which keep the allergic reaction and their symptoms 
ongoing [Wong et al., 2005]. 
The causes of asthma are not completely understood and are considered as 
multifactorial in origin [Wills-Karp, 2004]. Genetic and environmental factors are the 
most important risk factors that influence the development and expression of asthma 
[Tsicopoulos et al., 2013]. In conclusion, asthma mechanisms are complicated and the 
features of asthma are an outcome of the complexities of human genome including 
gene-gene as well as gene-environmental interactions [Lovinsky-Desir et al., 2012]. 
Occupational asthma (OA) is defined as asthma initiated by an airborne agent 
encountered in the workplace [Bernstein, 2003; Cromwell et al., 1979; Di Stefano et al., 
2004; Tarlo et al., 2003; Wild et al., 2003; Zeiss, 2002]. This includes also development 
or exacerbations of pre-existing asthma [Holsapple et al., 2006; Mapp et al., 1999]. OA 
prevalence was reported to range between 9% and 15% among the asthmatic population 
[Nicholson et al., 2005]. The onset of the disease can be induced by an immunologic 
response in the lung sensitized to an airborne agent inhaled at workplace, named 
sensitizer-induced OA [Birdi et al., 2013]. Sensitizer-induced OA which could be 
induced by industrial high molecular weight (HMW) substances such as proteins or 
polysaccharides [Wild et al., 2003], low molecular weight (LMW) chemicals, or metals 
[Bernstein, 2003; Di Stefano et al., 2004]. HMW proteins (more than 10 kDa) are 
generally derived from microorganisms, plants, or animals. Sensitization caused by 
HMW is initiated through classical IgE antibody and eosinophil inflammation [Wild et 
al., 2003]. In contrast to HMW allergens, LMW agents are less than 10 kDa and are 
mostly electrophilic, which have to form covalent bonds with nucleophilic amino acids 
such as lysine, cysteine, and histidine in the respiratory mucosa to become 
immunogenic [Sastre et al., 2003] (Figure 2).  
The traditional classification for hypersensitivity reactions was proposed by Gell and 
Coombs in 1963 and is currently the most commonly known classification system, 
which is divided into four types [Gell et al., 1963]. HMW substances are considered to 
act as common airborne allergens through IgE mediated responses, while the 
mechanisms by which LMW substances induce asthma may be different, for example 
isocyanates, acid anhydrides may lead to airway sensitization through non-IgE-mediated 
immunologic mechanisms that are only partially elucidated [Kenyon et al., 2012].  
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Figure 2: Sensitization caused by a LMW respiratory agent. The green pathway describes the molecular 
mechanism of sensitization. 
 
1.3.2 Mechanisms of non-immunologically mediated asthma  
The pathogenesis of OA can also be non-immunologic which is induced by rapid 
exposure to high concentrations of irritant at workplace or by chronic exposure to 
inhaled irritants, both of them named irritant-induced OA [Brooks et al., 2011; 
Verstraelen et al., 2008]. Irritant-induced asthma is a type of non-immunologic 
occupational asthma that prolonged bronchial hyperresponsiveness and airflow 
obstruction by inhaled substances. It can be induced by a single or multiple high- or 
low-dose exposures to injurious agents [Labrecque, 2012]. Reactive airway dysfunction 
syndrome (RADS) is the best known and characterized form of irritant-induced asthma 
caused by a single or multiple high-doses of respiratory injuries such as heated acids, 
toluene diisocyanates, and chlorine dioxide [Labrecque, 2012]. This type of asthma has 
the same symptoms as the immunological type whereas no latency period occurs. The 
onset of RADS symptoms occurs within 24 hours after exposure [Brooks et al., 2011]. 
It is dominated by an inflammatory reaction with unspecific immune cells eliminating 
the chemicals. Pathogenesis of RADS involves innate, non-adaptive immune responses 
and starts with bronchial epithelial injury and release of pro-inflammatory mediators 
which are also able to result in airway remodelling [Brooks et al., 2011].  
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1.4 Test methods for the identification of different sensitizers 
1.4.1 In vivo test methods for the identification of respiratory and contact 
sensitizers 
Respiratory sensitization is an immunological state of the respiratory tract that results 
from specific adaptive immune responses to antigenic exposure leading to 
hypersensitivity after subsequent exposure to the sensitizing substance. 
One of the well-established in vivo models for respiratory allergy research was the 
guinea pig model, which has been used for nearly a century [Magnusson et al., 1969]. In 
this model, the lung of guinea pig is the target organ for the identification of 
hypersensitivity exposed to respiratory sensitizer. It has been reported that the responses 
in guinea pigs are in a similar way as observed in human regarding lung injury, 
antibody responses, and respiratory sensitization [Briatico-Vangosa et al., 1994; Karol, 
1987]. However, there are a number of drawbacks in the use of guinea pig model of 
respiratory sensitization. For example, in guinea pigs the major class of antibody 
response is IgG, whereas in human IgE is the predominant class [Pauluhn et al., 2005; 
Ritz et al., 1993; Sarlo et al., 1992]. Furthermore, guinea pig has a prominent lung 
eosinophilia without antigen sensitization [Rothenberg et al., 1995]. Therefore, these 
disadvantages prohibited the development of guinea pig model as a prediction model for 
respiratory sensitizer. 
At present, the widely used alternative approach which based on the immunological 
events and responses that are provoked by contact allergens is the murine local lymph 
node assay (LLNA). The LLNA is a predictive test that uses in vivo cell proliferation in 
the draining lymph nodes for assessment of the contact sensitization of chemicals 
[Basketter et al., 2002; Magnusson et al., 1969; OECD Guideline 429, 2010]. The 
LLNA is the unique model which has been regulatory accepted and validated. The 
observed degree of lymphocyte proliferation has been shown to correlate well with the 
sensitization potency of the test material [Kimber et al., 1994]. This assay possessed 
several advantages over guinea pig sensitization assays, including the generation of 
quantitative dose-response data for addressing sensitization potency, the reduction and 
refinement of animal testing, and decreases of experimental time and costs [Anderson et 
al., 2011]. Originally, the LLNA was designed for predicting skin sensitizers, however, 
most respiratory sensitizers tested have also been shown to be positive [Boverhof et al., 
2008]. It appears that respiratory allergens can induce sensitization when applied 
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topically to the skin [Hilton et al., 1998]. In the modified LLNA, referred to as 
respiratory LLNA (which has not been validated yet), chemicals are inhaled, and 
enhanced proliferation of lymphocytes as well as the cytokine profile in the draining 
lymph nodes can be used to identify and distinguish strong contact and respiratory 
sensitizers [Arts et al., 2008; Basketter et al., 1992; de Jong et al., 2009; Kimber et al., 
2007; OECD Guideline 429, 2010; Van Och et al., 2002]. However, dermal application 
is the only route of exposure validated for the LLNA, which excluded allergens that 
cannot pass through the skin. There are currently no accepted and validated test methods 
to identify chemicals with a potential to cause respiratory sensitization [Holsapple et al., 
2006; Kimber et al., 1996; van Loveren et al., 2008]. The prevalence of both contact 
and respiratory sensitizations tends to grow proportionally to an expanding variety of 
chemicals. Therefore, further models are still required which can be used to assess the 
respiratory sensitizing potential of work-related agents. 
 
1.4.2 In vitro, in chemico, and in silico alternative test methods for the 
identification of sensitizers 
In vivo studies are very complex, cost-intensive and especially associated with pain and 
suffering of many laboratory animals. A continued challenge has been led to the 
development of in vitro approaches such as cell culture systems according to reduce, 
refine and replace the use of animals. The use of cultured DCs or DC-like cells is the 
most common method for the identification of sensitizers and for the further 
characterization of response through in vivo studies to differentiate respiratory from 
contact sensitizers. Human peripheral blood mononuclear cell-derived dendritic cells 
(PBMC-DC) have been utilized commonly to monitor the response to various 
sensitizers through studies on e.g. surface marker expression or gene expression 
responses, which support the identification of sensitizing potential [Hansen et al., 2005; 
Hulette et al., 2002; Larsson et al., 2009]. A number of dendritic-like cell lines have 
also been investigated including e.g. the human myeloid cell lines MUTZ-3 and THP-1 
for induction of respiratory sensitization reactions [Megherbi et al., 2009; Mitjans et al., 
2008; Nelissen et al., 2009; Python et al., 2009]. In the past years several in vitro assays 
have been already validated for screening toxicity in the context of REACH [Marx et 
al., 2007; Vitale et al., 2009]. The majority of validated and accepted alternative test 
methods were published for topical and oral applications. For example, skin irritation 
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test methods were applied not only in vivo methods but also in vitro testing (EpiskinTM, 
EpidermTM and SkinEthicTM) [Alepee et al., 2013; Curren et al., 2006; Hoffmann et al., 
2005; Tornier et al., 2010; Yuki et al., 2013]. Since July 2013 Regulation (EC) No 
1223/2009 of the European Parliament and of the Council on cosmetic products 
provides the prohibition of animal testing on cosmetic compounds which should be 
fully replaced by alternative methods [European Parliament, 2009]. But there is still no 
validated test method for the respiratory toxicity. 
Chemical substances (haptens) can trigger a sensitization reaction through binding to a 
protein by stable covalent bonds or coordination bonds. The study of chemical-protein 
reactivity in the sensitization process is an additional non-cell-based in vitro approach 
which is defined as in chemico study. A number of studies have used peptide reactivity 
assays for the identification of sensitizers by determining chemical-protein conjugates 
or by measuring the depletion of peptides [Gerberick et al., 2004; Gerberick et al., 
2007; Kato et al., 2003; Maxwell et al., 2011]. For example trimellitic anhydride and 
maleic anhydride have chemical characteristics containing functional groups such as 
anhydrides which are usually used to modify primary amines on proteins and providing 
reactive groups for subsequent reactions with e.g. proteins in biological environments 
[Lalko et al., 2012]. In summary, current in vitro and in chemico approaches for 
assessing the sensitization potential of substances have advantages in the understanding 
of chemical-induced and regulated cellular and molecular mechanisms. However, due to 
the complexity of the immune system, most in vitro or in chemico assays can only 
assess some aspects of the multi-step procedures required to achieve sensitization.  
Another alternative to animal model names in silico approaches, which identify 
allergens by using structure-activity relationships (SAR) [Seed et al., 2008]. SAR 
models are primarily based on chemical structure alerts and reactivity of functional 
groups with proteins by using many software applications like ChemProp and TIMES-
SS [Meinert et al., 2010; Patlewicz et al., 2007]. For example, a number of studies have 
described structural alerts with molecular sub-structures or fragments that contain an 
electrophilic or pro-electrophilic group within a molecule which can covalently bind to 
self-proteins for contact sensitization and contact irritation as for example glyoxal 
[Patlewicz et al., 2007]. Glyoxal is an extremely reactive Schiff base former that has 
been shown to be able to cross-link protein chains. This chemical is capable of cross-
linking proteins due to the two carbonyl groups, which allows mechanistic information 
to be used for hazard identification [Enoch et al., 2012; Marquie, 2001]. However, in 
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silico models show limitations due to complexity of the available databases and the use 
of software for unknown allergens [Thomas et al., 2005].  
1.5 PCLS reflect the natural immunological responses of the 
intact organ  
Organ slices have been used in biochemistry for studying basic pathways of 
intermediary metabolism for several decades [Warburg, 1923]. However, the production 
of identical slices in many of the early studies using manual techniques was difficult, 
being highly dependent on the experience of the investigator. The development of the 
Krumdieck tissue slicer, which improved culturing and slicing technologies by the 
production of consistent dimensions of slices with reduced stress for the tissue for the 
first time [Brendel et al., 1987; Krumdieck et al., 1980; Smith et al., 1985]. Live 
circular tissue slices of nearly identical diameter and thickness of thin circular sections 
can be generated from most tissues firstly by using a coring tool which cut the tissue 
into cylindrical tissue cores and subsequently by a microtome that cut by a rapidly 
oscillating disposable blade to the vertical main axis of the tissue core [Krumdieck, 
2013]. Krumdieck tissue slicer operates submerged in a cold isotonic medium that 
carries the cut slices outside the microtome. All the instruments can be sterilized and 
slices can be obtained at a constant rate [Krumdieck, 2013].  
The advantages of this organotypic lung tissue model are diverse. Firstly, thin slices of 
precise sectioning are able to generate reproducible results [Martin et al., 1996]. Due to 
improvements of the model by resting slices or better conditions like suitable culture 
medium along with others, it shows good reproducibility of findings [Switalla et al., 
2010b]. Secondly, PCLS provide physiological complexity of high biological relevance 
[Sewald et al., 2013; Switalla et al., 2010b]. They provide a unique approach to 
investigate integrated physiology that links the cellular and organ responses. They retain 
many aspects of the cellular and structural organization of the lung. The immune 
response of PCLS could be investigated on different levels (e.g. protein production, 
gene expression, and mediator release) and results could be extrapolated to in vivo 
immune responses [Sewald et al., 2013]. And thirdly, according to 3R concept, there is 
a public demand to limit the number of animals and reduce distress of laboratory 
animals. PCLS can produce copious numbers of slices which obtained from one lung 
lobe of different laboratory animals (e.g. mouse, rats, guinea pigs) and humans. Each 
experiment can be performed with each own internal control. Moreover, the dynamics 
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of macroscopic changes of bronchoconstriction associated with the airways could be 
observed with conventional microscopy [Schleputz et al., 2012; Seehase et al., 2011]. 
The microscopic changes associated with cellular events could be also observed with 
confocal or two photon microscopy [Sanderson, 2011].  
In the last years, the slice technique was established for a wide range of species such as 
rat, mouse, guinea pig, non-human primate, and human [Sewald et al., 2013]. Tissue 
slices could also be produced from a variety of different organs such as liver, kidney, 
heart, and lung [Bergner et al., 2002; De Kanter et al., 2004; Pushparajah et al., 2007]. 
Vital lung slices were used for the assessment of responses to immunomodulators like 
LPS and dexamethasone [Henjakovic et al., 2008; Seehase et al., 2012; Switalla et al., 
2010b], determination of genotoxicity using Comet assay [Switalla et al., 2013], studies 
on xenobiotics-mediated metabolism [De Kanter et al., 2004; Groothuis et al., 2013; 
Niu et al., 2013; Umachandran et al., 2004], investigations of small airways in the early 
allergic response, calcium signalling combined with bronchoconstriction, 
bronchoconstriction in non-human primate [Bergner et al., 2002; Seehase et al., 2011; 
Wohlsen et al., 2003], and other pharmacological and toxicological studies [Fisher et 
al., 2013; Monteil et al., 1999; Nassimi et al., 2009; Sturton et al., 2008]. PCLS have 
the ability to observe changes in cell physiology and subsequently these responses could 
be manifested themselves at the level of the organ, lung slices have become a standard 
tool for the investigation of lung disease. 
All these above mentioned aspects supported the development of PCLS in this doctoral 
thesis as an ex vivo model which could offer an appropriate way to assess local 
immunotoxicity. The aim of this doctoral thesis was firstly to analyse chemical-induced 
irritation and inflammation by assessing a variety of immunotoxic endpoints in human 
PCLS, and secondly to prevalidate the PCLS model as an organotypic tissue model for 
in vitro testing of starting concentrations for acute inhalation toxicity studies, which 
may ultimately lead to a refinement and reduction of animal testing. 
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2 Hypothesis 
A variety of in vitro and in vivo models were investigated for respiratory toxicity studies 
with different aspects. The most in vitro and in vivo models did not have the capability 
to extrapolate to the human situation due to lacking organ complexity and human 
physiology, respectively. Alternative methods for the assessment of chemicals for 
respiratory toxicity were only established through dermal route application in vivo or 
cell lines and three-dimensional (3D) models of respiratory tract in vitro in the last 
years, however, there are still no accepted and validated alternative methods for the 
identification of respiratory toxicity. 
Hypothesis of this doctoral thesis was that the identification of respiratory toxicants 
could be characterized by means of chemical-induced cytotoxicity and specific cytokine 
pattern in an organotypic lung tissue model PCLS.  
For proving this hypothesis, two different studies were investigated: 
1. Acute local respiratory irritation and inflammation were assessed in PCLS after 
exposure to well-known industry sensitizers and non-sensitizing irritants. Aim 
was to identify chemical-induced toxicity for the risk assessment of occupational 
asthma. 
2. The second study was focused on the prediction of chemical-induced toxicity, 
which aimed to prevalidate PCLS as a standardized tool of dose-finding at the 
beginning extrapolated to in vivo situation for acute inhalation toxicity studies.
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Legends for the Online Supplement 
 
Supplement 1: Image analysis of concentration-dependent cell death induced by Phe in 
human PCLS. Tissue slices were stained with 4 µM calcein AM and 4 µM EthD-1 after 
24-h incubation A) without Phe or with B) 250 µg/mL Phe, C) 500 µg/mL Phe, D) 
650 µg/mL Phe, and E) 1000 µg/mL Phe. Images were examined by confocal laser 
scanning microscopy (20× objective, excitation wavelengths 488 nm and 543 nm, 
emission filters BP 505–550 nm and LP 560 nm, thickness circa 30 µm, grid 
spacing = 50 µm) and F) analyzed with IMARIS 7.4.0. Red color shows cell nuclei (Ø 
5 µm) of dead cells and yellow color the cytoplasm of viable cells. Concentration-
dependent changes in human PCLS viability after cultivation with Phe or following cell 
lysis with Triton X-100. Results are given as numbers of 5 µm Ø spots (nuclei of dead 
cells) in 105 µm3 total tissue volume (cytoplasm of living cells). 
 
Supplement 2: Dose-response curves of the respiratory allergens TMA, HClPt, MA, 
and GA, the contact allergens 2-Bro, CinAld, CinOH, DNCB, Eug, PPD, Res, TMTD, 
Glyo, 2-Mer, and 4-Nit, and the non-sensitizing irritants Phe, LA, SA, SLS, and Glyc 
were generated for metabolic reduction of WST-1 to soluble formazan measured at 420-
480 nm. Data were normalized and the EC50 values were determined by nonlinear 
regression using sigmoidal dose-response.  
 
Supplement 3: Cytokine and chemokine production of IFN-γ, IL-10, TNF-α, RANTES, 
eotaxin-2, and IL-1α in A) human PCLS and B) mouse PCLS after 24-h submerse 
exposure to 64 µg/mL and 32 µg/mL HClPt, respectively. C) Cytokine and chemokine 
levels were represented percentage-wise to compare expression of cytokines and 
chemokines in different species (human and mouse). Cytokine and chemokine levels in 
culture supernatants and lysates were determined by MSD technology and ELISA. Data 
are shown as sum of extracellular and intracellular cytokine and chemokine production. 
Data for PCLS are presented as mean ± SEM, n=3, *p < 0.05; **p < 0.01 (Mann-
Whitney test). 
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Legends for the Online Supplement 
 
Supplement table 1: In-vivo toxicity data of each substance used in the prevalidation 
of rPCLS. Table shows for each substance: abbreviation according to table 1, in-vivo 
acute inhalation (inhal.) LC50 in µM, corresponding GHS classification, proposed 
mechanism of acute inhalation toxicity, in-vivo acute oral LD50 values in µmoL/kg body 
weight. 
Supplement table 2: Fulfillment of acceptance criteria. The table shows the number of 
samples entered for evaluation and the finally accepted numbers [%]. AC: acceptance 
criterion; N: number of analyzed samples. Lab.: laboratory. 
Supplement table 3: Intra-laboratory variability is shown for mean of log-transformed 
IC50 values [µM] of metabolic activity as assessed by WST-1 assay in each laboratory 
(A, B, C) with corresponding intra-laboratory standard deviation, coefficient of 
variation, and numbers of values included. Substances are ranked according to toxicity. 
Cv: coefficient of variation; Lab.: laboratory; Stdev: standard deviation; log IC50: log-
transformed IC50 [µM]. 
Supplement table 4: Intra-laboratory variability is shown for mean of log-transformed 
IC50 values [µM] of LDH activity as assessed by LDH assay in each laboratory (A, B, 
C) with corresponding intra-laboratory standard deviation, coefficient of variation, and 
number of values included. Absolutely no values were obtained for TX-100, TDI, 
ethanol, Ac2O, lactose, MMA, HCF, OC, and TMA. Substances are ranked according 
to toxicity. Cv: coefficient of variation; Lab.: laboratory; Stdev: standard deviation; log 
IC50: log-transformed IC50 [µM]. 
Supplement table 5: Intra-laboratory variability is shown for mean of log-transformed 
IC50 values [µM] for total protein as assessed by BCA assay in each laboratory (A, B, 
C) with corresponding intra-laboratory standard deviation, coefficient of variation, and 
numbers of values included. Substances are ranked according to toxicity. Cv: coefficient 
of variation; Lab.: laboratory; Stdev: standard deviation; log IC50: log-transformed IC50 
[µM]. 
Supplement table 6: Intra-laboratory variability is shown for mean of log-transformed 
IC50 values [µM] of intrinsic IL-1α (intIL-1α) as assessed by ELISA in each laboratory 
(A, B, C) with corresponding intra-laboratory standard deviation, coefficient of 
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variation, and numbers of values included. Substances are ranked according to toxicity. 
Cv: coefficient of variation; Lab.: laboratory; Stdev: standard deviation; log IC50: log-
transformed IC50 [µM]. 
Supplement figure 1: Correlation of recently published in-vitro studies using 3D 
models A) PCLS, B) MucilAir™, D) EpiAirway™ and monolayer cell lines, C) human 
A549 epithelial cells and E) 3T3 mouse embryonic fibroblasts (Sauer et al., 2013). IC50 
values were taken from Sauer et al., 2013, converted to molar mass and used for linear 
regression analysis with in-vivo inhalation LC50 values. In-vivo data were taken from 
online (Sigma, RTECS, ChemIDplus Lite, TOXNET, ECHA, and NIOSH Pocket Guide 
to Chemical Hazards) and converted to molar amounts (details are given in Supplement 
Table 1). For better comparison data sets were reduced to the lowest common number 
of chemicals. Fifteen identical chemicals provided values in every model. Hence, TX-
100, AHCP and ZnO were not included. 
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Supplement table 1 
 
# Substance In vivo  inhal. LC50 [µM] 
GHS 
classification Biological mechanisms** 
In vivo  
oral LD50 [µmol/kg] 
1 Paraquat 0.012 1 Oxidative stress, inhibition of respiratory chain 222 
2 IPDI 0.182 1 Respiratory irritation, respiratory sensitization 21715 
3 TX-100 0.622 2 Cell lysis 4328 
4 TDI 1.051 1 Respiratory irritation, respiratory sensitization 33295 
5 AHCP >2.552 4 Respiratory irritation, respiratory sensitization 439 
6 GA 3.202 2 Respiratory irritation 1339 
7 SDS >3.382 3 Cell lysis 4466 
8 OC 3.871 2 Lung edema 1961 
9 HCF 7.111 2 Lung edema Unknown 
10 FA 13.053 2 Respiratory irritation 3300 
11 TMA >23.952 4 Respiratory irritation, respiratory sensitization 13977 
12 Ac2O 26.001 2 Respiratory irritation, respiratory sensitization 17434 
13 Aniline 35.121,2 3 Respiratory irritation, bronchoconstriction 2685 
14 ZnO >70.022 5 Transient pulmonary inflammation 103649 
15 DMF 164.001 4 Respiratory irritation 38304 
16 MMA 297.701 5 Respiratory irritation 78641 
17 Ethanol 1149.671 5 Respiratory irritation 153145 
18 Acetone 1217.041 5 Respiratory irritation 122633 
19 Lactose Unknown 5 Unknown 29214 
20 Paracetamol Unknown 5 Liver toxicity 12857 
 1
 tested as vapor; 2 tested as aerosol; 3 tested as gas; * For Ac2O, TDI, Paraquat and acetone only LC50 values from studies with exposure 
durations different from 4 hours were found. In these cases, the LC50 values were converted to 4-hour LC50 values as described in the material 
section.**including cross-references from other toxicity studies 
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Supplement table 2 
 
Endpoint 
assay 
Acceptance 
criteria 
Lab. A Lab. B Lab. C 
N 
entered 
N [%] 
accepted 
N 
entered 
N [%] 
accepted 
N 
entered 
N [%] 
accepted 
WST-1 
AC1 216 100 216 100 216 100 
AC2 12 100 12 100 12 100 
AC3 12 100 12 100 12 100 
LDH 
AC1 216 100 216 100 216 100 
AC2 12 83 12 100 12 100 
AC3 12 100 12 100 12 92 
BCA 
AC1 48 100 32 100 56 98 
AC2 6 100 4 100 7 100 
AC3 6 100 4 100 7 100 
AC4 12 100 12 100 12 100 
ELISA 
AC1 96 95 32* 100 96 100 
AC2 12 100 4 100 12 100 
AC3 12 100 4 100 12 92 
AC4 12 83 12 50 12 100 
* AC1 for ELISA was not applied for laboratory B (equipped with pipetting robot) 
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Supplement table 3 
 
 
  
Intra-laboratory variability WST-1 assay 
# Substance Lab. Median log IC50 
Mean 
log IC50 
Stdev Cv [%] N 
 
TX-100 
A 1.91 1.79 0.27 15 3 
3 B 1.98 1.98 0.05 3 5 
 C 1.89 1.91 0.04 2 3 
 
SDS 
A 2.52 2.51 0.08 3 3 
7 B 2.42 2.40 0.19 8 5 
 C 2.42 2.25 0.24 11 2 
 
AHCP 
A 2.58 2.59 0.02 1 3 
5 B 2.63 2.61 0.12 5 4 
 C 2.61 2.60 0.03 1 3 
 
ZnO 
A 2.86 2.84 0.09 3 3 
14 B 3.06 3.11 0.26 8 3 
 C 2.85 3.03 0.34 11 3 
 
GA 
A 3.14 3.21 0.19 6 3 
6 B 3.16 3.12 0.27 9 4 
 C 2.86 2.98 0.23 8 3 
 
IPDI 
A 3.50* 3.49* NA NA 3 
2 B 3.13 3.09 0.27 9 3 
 C 3.16 3.18 0.51 16 3 
 
Paraquat 
A 3.27 3.08 0.38 12 3 
1 B 3.54 3.47 0.21 6 4 
 C 3.53 3.46 0.17 5 3 
 
FA 
A 3.61 3.72 0.27 7 3 
10 B 3.84 3.72 0.24 6 3 
 C 3.67 3.67 0.13 3 3 
 
TMA 
A 3.89 3.92 0.06 1 3 
11 B 4.00 3.99 0.05 1 3 
 C 4.68* 4.58* NA NA 2 
 
OC 
A 4.18 4.21 0.1 2 3 
8 B 4.14 4.17 0.06 1 3 
 C 4.21 4.19 0.03** 1** 2 
 
Ac2O 
A 4.25 4.22 0.07 2 3 
12 B 4.18 4.13 0.09 2 5 
 C 4.19 4.21 0.07 2 3 
 
HCF 
A 4.42 4.41 0.12 3 3 
9 B 4.32 4.32 0.14 3 5 
 C 3.93 3.96 0.51 13 3 
 
Aniline 
A 4.77 4.77 0.01 0.2 3 
13 B 4.83 4.78 0.16 3 5 
 C 4.27 4.29 0.38 9 3 
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TDI 
A 4.83 4.86 0.1 2 3 
4 B 4.71 4.70 0.19 4 4 
 C 5.23* 4.95 0.63 13 3 
 
Paracetamol 
A 4.68 4.78 0.18 4 3 
20 B 5.07* 5.07* 0.24 5 5 
 C 4.94 4.92 0.09 2 3 
 
MMA 
A >5.70 >5.70 - - 3 
16 B >5.70 >5.70 - - 4 
 C >5.70 >5.70 - - 3 
 
Lactose 
A >5.70 >5.70 - - 3 
19 B >5.70 5.68* - - 4 
 C 5.58* 5.30* 0.4 7 2 
 
Acetone 
A 6.11 6.11 0.1 2 3 
18 B 6.05 6.05 0.1 2 3 
 C 6.41 6.31 0.15 2 2 
 
DMF 
A 6.04 6.03 0.09 1 3 
15 B 6.14 6.13 0.07 1 3 
 C 6.25 6.18 0.19 3 3 
 
Ethanol 
A 6.15 6.14 0.02 0.3 3 
17 B 6.17 6.17 0.05 1 3 
 C 6.22 6.22 0.07 1 3 
NA, not analysed; * Value(s) found by extrapolation above the maximum applied concentration; ** For 
one run only a lower bound could be determined. This data point was detected as outlier by the Grubbs 
test (Grubbs, 1950) and not considered for the calculation of standard deviation and cv. 
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Supplement table 4 
 
 
  
Intra-lab. variability LDH assay 
# Substance Lab. Median 
log IC  
Mean 
log IC  
Stdev Cv [%] N 
 
SDS 
A 2.46 2.46 0.02 1 2 
7 B - - - - - 
 C - - - - - 
 
AHCP 
A 2.83 2.83 0.15 5 2 
5 B 3.03* 3.03* 0.02 1 4 
 C 2.94 2.84 0.25 9 3 
 
ZnO 
A 2.80 2.84 0.09 3 3 
14 B 2.99 2.99 0.18 6 3 
 C 3.43* 3.43* 0.13 4 2 
 
IPDI 
A - - - - - 
2 B 3.64* 3.71* 0.12 3 3 
 C - - - - - 
 
GA 
A - - - - - 
6 B - - - - - 
 C 3.71* 3.71* 0.16 4 2 
 
Paraquat 
A - - - - - 
1 B 3.92 3.83 0.5 13 4 
 C 4.56 4.56 0.04 1 2 
 
FA 
A 4.38 4.29 0.18 4 3 
10 B 4.39 4.36 0.09 2 3 
 C 4.31 4.27 0.08 2 3 
 
Aniline 
A 4.92 4.93 0.04 1 3 
13 B 4.94 4.92 0.03 1 5 
 C 5.20* 5.17* 0.15 3 3 
 
Paracetamol 
A 5.15* 5.15* 0.13 2 3 
20 B 5.08* 5.11* 0.13 3 6 
 C 5.19* 5.1* 0.19 4 3 
 
DMF 
A >7.10 >7.10 - - 2 
15 B 6.29 6.29 0.03 0.4 2 
 C 6.26 6.28 0.04 1 3 
 
Acetone 
A 6.46 6.46 0.08 1 2 
18 B - - - - - 
 C 6.58* 6.58* 0.18 3 2 
* Value(s) found by extrapolation above the maximum applied concentration 
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Supplement table 5 
 
 
 
  
Intra-lab. variability BCA assay 
# Substance Lab. Median log IC50 
Mean 
log IC50 
Stdev Cv [%] N 
 
TX-100 
A 2.20 2.21 0.16 7 3 
3 B 2.25 2.29 0.12 5 7 
 C 2.27 2.22 0.09 4 3 
 
SDS 
A 2.63 2.63 0.02 1 3 
7 B 2.55 2.55 0.01 0.3 2 
 C 2.71 2.71 0.15 5 2 
 
AHCP 
A 3.25* 3.23* 0.17 5 3 
5 B 3.11* 3.21* 0.29 9 3 
 C 3.13* 3.06* 0.12 4 3 
 
ZnO 
A 3.67* 3.67* 0.29 8 2 
14 B 3.46* 3.46* 0.06 2 2 
 C 3.03 3.12 0.21 7 3 
 
GA 
A 4.04* 3.93* 0.19 5 3 
6 B 3.49 3.57 0.36 10 3 
 C 3.68 3.77* 0.23 6 3 
 
TMA 
A 4.06 4.06 0.01 0.2 3 
11 B 4.06 4.06 0.04 1 3 
 C >5.00 >5.00 - - 2 
 
IPDI 
A >4.10 >4.10 - - 2 
2 B >4.10 >4.10 - - 1 
 C 2.93 2.93 0.12 4 2 
 
OC 
A 4.22 4.22 0.01 0.1 3 
8 B 4.24 4.30 0.10 2 3 
 C 4.24 4.26 0.08 2 3 
 
Ac2O 
A 4.29 4.28 0.02 0.5 3 
12 B 4.25 4.27 0.05 1 3 
 C 4.35 4.43 0.15 3 3 
 
FA 
A 4.45 4.45 0.03 1 2 
10 B 4.80* 4.82* 0.14 3 3 
 C 4.50* 4.48* 0.05 1 3 
 
HCF 
A 4.64 4.68 0.18 4 3 
9 B 4.61 4.58 0.19 4 5 
 C 4.67 4.70 0.43 9 3 
 
Paraquat 
A >5.30 >5.30 - - 3 
1 B 4.71* 4.75* 0.09 2 3 
 C 4.84* 4.84* 0.46 10 2 
 
Aniline 
A 5.08* 5.08* 0.04 1 2 
13 B 4.93 4.93 0.01 0.2 4 
 C 4.88 4.55 0.70 15 3 
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TDI 
A 4.98 4.98 0.10 2 2 
4 B 4.77 4.77 0.31 7 2 
 C >5.70 >5.70 - - 2 
 
Paracetamol 
A >5.65 >5.65 - - 3 
20 B 5.17* 5.21* 0.18 3 5 
 C 5.28* 5.28* 0.30 6 2 
 
Lactose 
A >5.70 >5.70 - - 3 
19 B >5.70 >5.70 - - 6 
 C 5.59* 5.59* 0.01 0.1 2 
 
MMA 
A >5.70 >5.70 - - 3 
16 B >5.70 >5.70 - - 3 
 C >5.70 >5.70 - - 3 
 
DMF 
A 6.26 6.28 0.04 1 3 
15 B 6.37 6.37 0.01 0.1 3 
 C 6.38 6.39 0.02 0.3 3 
 
Ethanol 
A 6.42 6.40 0.03 1 3 
17 B 6.43 6.52 0.24 4 3 
 C 6.43 6.63 0.38 6 3 
 
Acetone 
A 6.59* 6.57* 0.24 4 3 
18 B 6.31 6.32 0.07 1 3 
 C >7.18 >7.18 - - 2 
* Value(s) found by extrapolation above the maximum applied concentration 
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Supplement table 6 
 
 
  
Intra-lab. variability intIL-1α ELISA 
# Substance Lab. Median log IC50 
Mean 
log IC50 
Stdev Cv [%] N 
 
TX-100 
A 2.03 2.12 0.22 10 3 
3 B 2.29 2.22 0.12 5 3 
 C 2.21 2.18 0.08 3 3 
 
SDS 
A 2.62 2.59 0.10 4 3 
7 B 1.55 1.64 0.20 12 4 
 C 2.40 2.40 0.03 1 2 
 
AHCP 
A 2.65 2.67 0.12 4 3 
5 B 2.83 2.81 0.18 6 4 
 C 3.10* 3.02* 0.16 5 3 
 
ZnO 
A 3.18 3.04 0.38 12 3 
14 B 3.08 3.08 0.21 7 2 
 C 3.00 2.94 0.34 12 3 
 
GA 
A 3.46 3.46 0.11 3 2 
6 B 3.10 2.93 0.47 16 3 
 C 3.23 3.23 0.06 2 2 
 
IPDI 
A >4.10 >4.10 - - 2 
2 B 2.76 2.70 0.11 4 3 
 C >4.10 >4.10 - - 2 
 
FA 
A 3.90 3.90 0.3 8 2 
10 B 3.59 3.59 - - 1 
 C 3.53 3.53 1.78 50 2 
 
TMA 
A 4.03 4.02 0.04 1 3 
11 B 3.97 3.97 0.05 1 3 
 C >5.00 >5.00 - - 2 
 
HCF 
A 4.49 4.42 0.14 3 3 
9 B 3.62 3.56 0.32 9 3 
 C 4.17 4.33 0.30 7 3 
 
OC 
A 4.23 4.24 0.07 2 3 
8 B 4.33 4.29 0.38 9 4 
 C 4.13 4.11 0.05 1 3 
 
Ac2O 
A 4.29 4.28 0.04 1 3 
12 B 4.09 4.11 0.05 1 3 
 C 4.29 4.29 0.04 1 2 
 
Paraquat 
A 4.94* 4.94* 0.19 4 2 
1 B 4.58 4.48 0.67 15 3 
 C 4.49 4.73* 0.46 10 3 
 
Aniline 
A 4.75 4.75 0.12 3 2 
13 B 4.79 4.78 0.07 1 3 
 C 3.67 3.84 0.45 12 3 
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TDI 
A 4.80 4.72 0.28 6 3 
4 B 4.61 4.25 0.98 23 3 
 C >5.70 >5.70 - - 2 
 
Paracetamol 
A 4.83 4.86 0.06 1 3 
20 B 4.87 4.87 0.00 0 2 
 C 4.84 4.90 0.15 3 3 
 
MMA 
A >5.70 >5.70 - - 2 
16 B 5.42* 5.42* 0.29 5 2 
 C 4.75 4.75 0.53 11 2 
 
Lactose 
A >5.70 >5.70 - - 2 
19 B 5.20* 5.20* 0.06 1 2 
 C >5.70 >5.70 - - 2 
 
DMF 
A 6.07 6.05 0.04 1 3 
15 B 6.15 6.15 0.08 1 2 
 C 6.13 6.22 0.17 3 3 
 
Ethanol 
A 6.28 6.28 0.03 0.5 2 
17 B 6.18 6.18 0.04 1 2 
 C 6.27 6.27 0.06 1 2 
 
Acetone 
A 6.30 6.30 0.18 3 2 
18 B 6.10 6.10 - - 1 
 
 
C >7.18 >7.18 - - 2 
* Value(s) found by extrapolation above the maximum applied concentration  
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5 General discussion 
The data presented in this thesis addressed two different functional issues: at the 
beginning, the aim was to identify chemical-induced acute irritation and inflammation 
in the airway by using the organotypic lung model PCLS. Our preliminary results show 
that chemical-induced irritation could be predicted by the assessment of local 
respiratory toxicity in PCLS. However, chemical-induced inflammation in the airway 
could not be implicated by a simple screening of respiratory allergens in PCLS due to 
missing connections to the blood and lymph system in response to allergens 
(publication: "Assessment of immunotoxicity induced by chemicals in human precision-
cut lung slices (PCLS)"). Subsequently, PCLS was standardized and prevalidated as an 
alternative ex vivo approach to reduce the number of animals used in inhalation toxicity 
studies in three independent laboratories (publication: "Prevalidation of the ex-vivo 
model PCLS for the prediction of respiratory toxicology"). 
 
5.1 Chemical-induced toxicity in the development of acute lung 
injury 
5.1.1 Inhalation of toxicants leading pulmonary epithelial injury 
Pulmonary epithelial injury including pulmonary microvascular endothelial cell injury 
and barrier dysfunction could lead ongoing effects of acute lung injury that can 
subsequently induce pulmonary edema and migration of circulating neutrophils into the 
alveolar spaces [Lucas et al., 2009; Razavi et al., 2004; Wang et al., 2013; Wang et al., 
2002]. Inhalation of toxicants has been shown to cause epithelial death in sensitive cells 
regulated either by necrosis or apoptosis [Vyas et al., 2013]. Apoptosis and necrosis 
could be recognized based on differences in the morphological, biochemical, and 
molecular changes of dying cell [Vyas et al., 2013]. Necrosis is mostly directly induced 
by an overdose of toxic substance and responded to a massive injury [Vyas et al., 2013]. 
The factors which orchestrate the apoptotic process are diverse including noxious 
agents, oxidative stress, and other numerous intrinsic or extrinsic factors [Elmore, 
2007]. For example, chemicals like glyoxal leads to cell toxicity by the production of 
ROS, which degrades the mitochondrial membrane leading to cell apoptosis or induces 
lipid peroxidation and formaldehyde formation [Shangari et al., 2004]. Formaldehyde 
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interferes with airway integrity and functions and induces airway inflammation [Kastner 
et al., 2011]. Chemicals like eugenol could generate ROS and phototoxicity in solutions 
with various pH and trigger apoptosis [Atsumi et al., 2001]. Nevertheless, the precise 
molecular requirements that activate the apoptotic pathway remain largely unknown. 
For example, ROS could be produced in the metabolism of industrial chemicals by e.g. 
cytochrome P450 to free radical products and initiates apoptosis response [Parke et al., 
1996]. 
  
5.1.2 Assessment of toxic features of acute lung injury in live lung sections 
Recently, in regard to respiratory system several 3D models of human-derived 
epithelium which closely resembles the epithelial tissue of the respiratory tract than 
single cell line were used as in vitro assays for the assessment of toxic features of acute 
lung injury, such as EpiAirwayTM (MatTek Corporation, Ashland, MA, USA) and 
MucilAirTM (Epithelix Sarl, Geneva, Switzerland). However, the cellular anatomy of the 
respiratory tract comprises at least 45 extensively varying cell types with different 
functions, individual cell types may respond quite differently to the same substance. 
The ongoing development of in vitro toxicological test methods led to the advanced 
investigation of the potential application of new test methods as an alternative for 
toxicity testing of common workplace harmful substances. Therefore, the organotypic 
model PCLS was investigated in the present study by measuring different cytotoxic 
endpoints. In our workgroup, an air-liquid interface culture of murine PCLS was 
already established as a model system exposed to O3 and NO2 as model gas compounds 
to mimic the acute toxicity in acute lung injury [Switalla et al., 2010a]. In the present 
study, we tried to understand mechanism of chemical-induced respiratory toxicity to 
mimic the toxic features of acute lung injury. The endpoints were (a) the released 
cytosolar enzyme lactate dehydrogenase in the culture medium, (b) the remaining 
mitochondrial enzyme activities in the lung tissue slices, and (c) imaging analysis by 
live/dead fluorescence staining. 
Firstly, cell death was measured by the release of lactate dehydrogenase in the culture 
medium, however, accurate detection was not successful for all chemicals since 
exposure to a lot of chemicals failed to increase lactate dehydrogenase release due to 
chemical properties. In the modified protocol chemicals was exposed for one hour and 
changing the culture medium for further 23 hours post-incubation. Some substances led 
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to membrane damage during the exposure time in such amount, that a large part of the 
LDH was washed out together with the substance after the one hour exposure. Hence 
not all LDH could be determined after the post-incubation time. 
Acute respiratory toxicity of test chemicals was assessed mainly by the measurement of 
quantified number of metabolically active cells in human and rat PCLS. Our results 
clearly showed that chemical-induced respiratory toxicity was concentration-
dependently. Rather than single chemical concentration studies, dose-response curves of 
test chemicals were achieved and EC50 values were estimated for all tested chemicals. 
The most toxic chemical was glyoxal and triton X-100 among different selected test 
chemicals in human and rat PCLS, respectively. Glyoxal is known to attack amino 
groups of proteins, nucleotides and lipids. This leads to inactivation of enzymes, 
disturbance in the cellular metabolism, impaired proteolysis, and inhibition of cell 
proliferation and protein synthesis [Shangari et al., 2004]. Triton X-100 is an nonionic 
detergent, which is mostly used for lysing cells to extract protein and other cellular 
organelles and also used as membrane permeabilizing agents [Koley et al., 2010].  
Four chemicals (trimellitic anhydride, ammonium hexachloroplatinate, sodium dodecyl 
sulfate, and glutaraldehyde) were assessed either in human or in rat PCLS (Table 1). 
The most and least toxic chemicals were sodium dodecyl sulfate and trimellitic 
anhydride in both species by using WST-1 cell proliferation assay, respectively. Sodium 
dodecyl sulfate is mostly used as anionic detergent which can totally disrupt cell 
membranes and denature proteins at higher concentrations [Chaturvedi et al., 2011]. It 
was reported trimellitic anhydride exhibits low acute toxicity by the oral, dermal, and 
inhalation routes [OECD SIDS, 2002]. Respiratory toxicity of these four test chemicals 
could be translated from rat to human situation in PCLS for human toxicological risk 
assessments. 
Chemical 
name 
CAS # M [g/mol] Class 
Rat          
PCLS EC50 
[µg/mL] 
Human   
PCLS EC50 
[µg/mL] 
Trimellitic anhydride 552-30-7 552-30-7 Anhydrides 3119 761 
Ammonium 
hexachloroplatinate 
16919-58-7 443.9 Metal compounds 177 193 
Glutaraldehyde 111-30-8 100.1 Aldehydes 127 58 
Sodium dodecyl sulfate 151-21-3 288.4 Detergents 96 55 
 
Table 1: Four test substances were tested either in rat PCLS or in human PCLS model. Table shows for 
each substance: chemical name, CAS-number, molecular weight, chemical class, EC50 (effective 
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concentration at 50 % reduction of cell viability) values of chemicals were calculated on the basis of 
dose-response curves assessed by WST-1 reduction 
In order to ensure the reliability of measured cell viability, a microscopy-based 
approach was chosen. Live cells were visualized by calcein acetoxymethyl (calcein 
AM), a lipid soluble fluorogenic diester that can passively cross the cell membrane in an 
electrically neutral form. Calcein AM can be converted by intracellular esterases into 
negatively charged fluorescent analogue [Neri et al., 2001]. In cells undergoing 
apoptosis, early chromatin condensation could be visualized as increased signal 
intensity, since non-specific esterase is also present in nuclei [Böcking, 1974]. Figure 
3A showed one example in mouse PCLS exposed to increased concentrations of 
trimellitic anhydride, a stronger signal intensity could be observed at 25 µg/mL and 50 
µg/mL, which could indicate the beginning of apoptosis [Palma et al., 2008]. 
Subsequently, cell membrane permeability increased, esterase activity decreased and 
ethidium homodimer (EthD-1) reacted with nucleic acids (red fluorescence), which also 
reflected the physical alteration in the epithelial [Gatti et al., 1998]. The morphology of 
tissue slices could be regarded as a sufficient tool for adequate identification of cell 
death with regard to apoptosis. Dead cells could be quantified in percentage terms by 
the total volume of viable cells with the help of a software (IMARIS 7.4.0.) (Figure 3B). 
A 
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B 
  
Figure 3: A) Image analysis of mouse PCLS exposed to TMA with at different concentrations (3.12 
µg/ml – 300 µg/ml). The first and the last images were tissue control with DMEM and 0.5% Triton X-100 
control, respectively. Tissue slices were stained with 4 µM calcein AM and 4 µM EthD-1 after 24 h of 
submerged cultivation; B) The images were examined by two-colour confocal laser scanning microscopy 
and analyzed with IMARIS 5.5.3. Red colour shows cell nuclei (∅ 5 µm) of dead cells and green colour 
the cytoplasm of viable cells (grid spacing = 20 µm). Concentration-dependent changes in mouse PCLS 
viability after cultivation with TMA. Results are given as numbers of 5 µm Ø spots (nuclei of dead cells) 
in 105 µm3 total tissue volume (cytoplasm of living cells). 
 
5.2 Chemical-induced toxicity in the development of non-
immunologically mediated occupational asthma 
5.2.1 Measurement of cytokines for the assessment of chemical-induced 
inflammation in PCLS model 
It is known that airway epithelial cells, alveolar macrophages are capable to secret early 
chemoattractant and pro-inflammatory cytokines like IL-8, IL-1α and TNF-α in direct 
response to viral and bacterial infections, noxious gases, and sensitizing chemicals 
[Parker et al., 2011]. Chemokine IL-8 was described recently as biomarker for 
identification of allergens in human promyelocytic cell line THP-1 [Mitjans et al., 
2008]. Unfortunately, solvent DMSO which was used to dissolve respiratory sensitizer 
glutaraldehyde, trimellitic anhydride, and maleic anhydride induced high amounts of IL-
8 in human PCLS. The solvent was not toxic at the final concentration used, but an 
influence on cells cannot be excluded. Beside the influence of DMSO on cells, the 
human tissue reactivity could be another possible factor because 80% of the lungs were 
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obtained from smokers of 60 ± 10 years old donors. Therefore, IL-8 is not suitable to be 
used as biomarker for the screening of potential chemical sensitizers in human lung 
tissue. It has been shown that both early response pro-inflammatory cytokines TNF-α 
and IL-1 contribute to alveolar epithelial barrier dysfunction in acute lung injury [Frank 
et al., 2008; Patel et al., 2013; Pugin et al., 1996]. In human PCLS, pro-inflammatory 
cytokine TNF-α or IL-1α was increased significantly after exposure to respiratory 
allergens at subtoxic concentrations, while contact sensitizers and non-sensitizing 
irritants failed to induce release of these cytokines to the same extent. Respiratory 
allergen maleic anhydride could induce neither TNF-α nor IL-1α production. The basic 
control used for the measurement of IL-1α was too high due to the reactivity of human 
lung donor mentioned before. In conclusion, production of pro-inflammatory cytokines 
TNF-α or IL-1α exposed to respiratory sensitizers could amplify ongoing inflammatory 
processes via the recruitment and activation of specific subsets of inflammatory cells as 
well as changes of structural cells in the form of increased smooth muscle mass, 
subepithelial fibrosis, vascular proliferation in the airway tissue [Laberge et al., 2004; 
Osorio et al., 2013]. However, pro-inflammatory cytokines TNF-α and IL-1α cannot be 
considered as biomarkers for the differentiation between respiratory and contact 
sensitizers. Moreover, we have seen positive results of cytotoxicity-induced increase of 
extracellular IL-1α in rat PCLS after exposure to acetic anhydride and ammonium 
hexachloroplatinate, which are known to induce respiratory inflammation. On the 
contrary, non-sensitizing substances such as lactose and MMA showed absolutely no 
effect on extracelluar IL-1α. These results encourage the vision that pro-inflammatory 
cytokine like IL-1α could be a valuable marker for prediction of substance induced 
inflammatory effects. 
It has been reported that respiratory sensitizers favor association with soluble proteins 
whereas contact allergens preferentially bind to cellular proteins before the allergic 
response begins [Hopkins et al., 2005]. The selective chemical-protein binding ability 
may indicate an early determinant of the form that allergic responses to respiratory or 
contact sensitizers will take place. The selective haptenation of cellular or extracellular 
protein by chemical allergens is associated with cytokine polarization, which was 
described in vivo that respiratory sensitizers caused statistically significant increases in 
TH2-type cytokine release including IL-4, IL-5, and IL-13, whereas contact sensitizers 
induced predominantly TH1-type cytokine response and mainly IFN-γ production [de 
Jong et al., 2009; Dearman et al., 1999; Mori et al., 2012]. In human lung slices, typical 
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TH1/TH2 cytokine profiles could not be detected by measurement of the 
cytokines/chemokines production of IL-10, IL-2, IL-13, IL-5, IFN-γ, and eotaxin-2 
exposed to respiratory allergens trimellitic anhydride and ammonium 
hexachloroplatinate compared to contact allergens and non-sensitizing irritants. It has 
been shown in vitro that enriched DC from atopic donors showed no significant 
alteration in either cytokine production or T cell stimulatory capacity after exposure to 
respiratory and contact sensitizers due to human donor variability [Holden et al., 2008]. 
Lack of T cell responses in human tissue after transplantation is one possible 
explanation for sensitization deficiency to both respiratory and contact sensitizers. 
Additionally, loss of allergenic potential in aqueous environment like trimellitic 
anhydride should be considered as another cause of defect [OECD SIDS, 2002]. 
Interestingly, all the cytokines/chemokines including TH1/TH2 cytokines IL-5, IL-13, 
IL-10, IFN-γ, regulatory T cells (Tregs) cytokine IL-2, and eosinophil chemotactic 
protein (eotaxin-2) were increased significantly after exposure to ammonium 
hexachloroplatinate at subtoxic concentration. The hypothesis is that human lung tissue 
from patients had been pre-sensitized by soluble platinum salt belonged to platinum 
group elements (PGEs), in which the greater proportion of PGE are emitted from 
automobile vehicle exhaust catalysts (VECs) in the environment. PGE emissions can be 
deposited on road dusts consequently, it enters into water, soil, and food chain. Several 
studies have reported that PGE may be transformed into ions solubilized in human body 
fluids and tissues like hexachloroplatinate and tetrachloroplatinate which belong to the 
most potent allergens associated with asthma and other serious health problems in 
human [Konieczny et al., 2013; Ravindra et al., 2004; Wiseman et al., 2009]. In the 
present study, we compared the sensitization potential of ammonium 
hexachloroplatinate in both mouse and human PCLS through the measurement of 
extracellular and intracellular production of IFN-γ, IL-10, IL-8, TNF-α, RANTES, 
eotaxin-2, and IL-1α. Mouse tissue was used as control without any pre-treatment. Test 
concentrations of ammonium hexachloroplatinate have been controlled to avoid 
unspecific cytokine changes regarding reduced cell viability. In mouse PCLS, cytokines 
remained unchanged after 24-hour exposure to ammonium hexachloroplatinate whereas 
significant increases of IFN-γ, RANTES, and eotaxin-2 could be detected in human 
PCLS. Therefore, the donors of human lung material used might have been exposed to 
some of the platinum group elements, which conjugated with human carrier proteins 
and provoked a specific immune response through the complete haptenated antigen. The 
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haptenated antigen could induce firstly pro-inflammatory cytokine production and 
subsequently circulate dendritic antigen-presenting cells and regulatory T lymphocyte 
functions leading production of memory T cells in the body [Burastero et al., 2009]. 
Antigen-specific memory T cells persist at many sites in the body, infection of the lung 
could result the migration of a greater numbers of recall memory T cells at lung 
peripheral sites [Woodland et al., 2009]. Moreover, it has been reported that numerous 
resident memory T cells are present in human lung tissues where they provide a first 
line of defense against secondary antigens [Purwar et al., 2011]. Once the antigen 
specific memory T cells activated, increases of TH1/TH2 cytokines could be detected in 
the lung tissue [Ndejembi et al., 2007]. Thus, the sensitization potential of the 
accumulation of PGEs from automobile catalysts indicates that environmental 
exposures to metal may pose human health risk and elicit allergenic reactions. 
 
5.2.2 Live lung sections for the risk assessment of non-immunologically 
mediated occupational asthma 
Non-immunologically mediated occupational asthma is dominated by an inflammatory 
reaction with immune cells and cytokine release aiming to eliminate the irritant 
chemicals [Tarlo, 2014]. RADS is one typical form of non-immunological asthma 
which starts with bronchial epithelial injury and release of pro-inflammatory cytokines 
leading to airway hyperresponsiveness [Brooks et al., 2011]. The mechanism of irritant-
induced asthma may be mediated by neural reflexes [Alarie, 1973; Nielsen, 1991]. 
Substantial properties, the concentration and the duration of exposure enable a 
substance to bind to and activate irritant receptors of specific ion channels of sensory 
neurons innervating the airways, for example irritant-sensing ion channel (e.g. TRPA1) 
[Caceres et al., 2009; Bautista et al., 2006]. The sensory nerves can secrete pro-
inflammatory neuropeptides such as Substance P and cause a neurogenic inflammation 
at the side of contact with the chemical by stimulating different immune cells as well as 
epithelial cells to release pro-inflammatory cytokines [Meggs, 1994] (Figure 4). If an 
irritant chemical is corrosive or inhaled at a very high concentration it could also 
directly damage the respiratory epithelial cells and therefore enhance the potential for 
developing neurogenic inflammation [Lutz et al., 2004]. In chapter 5.1 acute lung injury 
induced by chemicals could be assessed in live lung sections. As mentioned above, the 
pro-inflammatory cytokine TNF-α or IL-1α was increased significantly after exposure 
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to respiratory chemicals at subtoxic concentrations. In summary, the live lung sections 
could be used for the first risk assessment of toxic chemicals for non-immunological 
asthma at the workplace.  
 
Figure 4: Irritation caused by a LMW agent. The blue pathway shows the molecular mechanism of 
irritant-induced neurogenic inflammation. 
 
5.3 Predictivity of the ex vivo model PCLS for respiratory 
toxicology 
5.3.1 Reproducibility of PCLS in rat 
Generally, alternative toxicity testing methods have to be validated which is crucial for 
the reliability and reproducibility for the intended purpose before they can receive 
regulatory approval. We have investigated a standard process using rat PCLS exposed 
to twenty chemicals with optimized protocols in three independent laboratories. After 
testing of the first six substances, variability of different toxicological endpoints within 
and between laboratories was evaluated, in which different acceptance criteria (ACs) 
were defined for each different assay. Four assays including WST-1 and LDH assays for 
the cytotoxicity, BCA assay for the measurement of total protein in slices, and IL-1α as 
biomarker for inflammation have been used as endpoints in rat PCLS. After setting of 
protocols with defined ACs, standard operation procedures (SOPs) for all endpoints 
were distributed to each laboratory for further testing of the rest fourteen industrial 
chemicals.  
Intra- and inter-laboratory variability was evaluated for each endpoint. Log10[EC50 
(µM)] obtained for all assay endpoints showed best intra- and inter-laboratory 
consistency for the data obtained by WST-1 and BCA assays, in which WST-1 assay 
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was supported to be the best suitable analysis for cytotoxicity. The reason is that BCA 
assay was less sensitive to cytotoxicity shown by the fact that for some substances 
(isophorone diisocyanate, dimethylformamide, ethanol) cytotoxicity was found by 
WST-1 assay but the maximum concentration was not high enough to induce loss of 
total protein in the BCA assay. And LDH assay was not suited in the short-term 
exposure with post-incubation due to washout effect. IL-1α as biomarker for 
inflammation was less reproducible and sensible due to specific laboratory conditions. 
In summary, WST-1 assay was the best transferable assay for chemical-induced 
cytotoxicity and showed the least intra- and inter-laboratory variability that can provide 
valid and reproducible results. The test protocol used in this study is adequately 
transferable for practical use. 
 
5.3.2 Correlation of PCLS to published in vitro models  
The microanatomy of PCLS for the assessment of acute local respiratory toxicity 
induced by chemicals was comparable with in vitro different cell lines and 3D models. 
Comparison of the human PCLS with in vitro models showed that the EC25 values in 
human PCLS correlated significantly with the EC25 values in human promyelocytic 
cells (THP-1) and in human keratinocyte cells (NCTC 2455), in which higher value of 
correlation was shown in THP-1 cells than in NCTC cells, which suggested that cells in 
human PCLS behave more like monocyte-derived cells regarding their resistance to 
chemicals than skin-derived epithelial cells. 
The EC50 values in rat PCLS correlated also significantly with two 3D models: 
MucilAir™ and EpiAirway™, and two other single cell lines: adenocarcinomic alveolar 
type II basal epithelial cells (A549) and mouse embryonic cells (3T3). Two 3D models 
correlated better than single cell line models, suggesting that cells in rat PCLS behave 
more like bronchial epithelial cells isolated from biopsies than primary human tracheal 
or bronchial epithelial cells.  
Remarkably, the spreading of the toxicity data in all tested models has a common 
feature that EC50 values were much closer in single-cell cultures than PCLS model and 
3D models. The wide range of distribution for PCLS and 3D models could also be 
found for in vivo toxicity data of inhalation toxicity studies after exposure to the same 
substances.  
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5.3.3 Assessment of in vivo relevance of PCLS model 
The EC50 values of test chemicals in both human and rat PCLS were compared to acute 
inhalation LC50 values for rat taken from published toxicological databases. Regression 
analysis indicated significant correlations between ex vivo and published in vivo 
inhalation toxicity data for selected industrial chemicals (p < 0.01). Pearson’s 
correlation coefficient with in vivo toxicity data from online inhalation studies was less 
comparable to human PCLS (Pearson r = 0.7) than rat PCLS (Pearson r = 0.9). And the 
toxicity in the rat PCLS model correlated also highly significantly with LD50 values 
from in vivo rat oral studies (Pearson r = 0.8). The correlations showed less variability 
in the same species compared to human. In principle, for in vivo relevant assessment it 
was necessary to compare and correlate the data obtained from human studies since the 
physiological and biochemical dissimilarities of animal models [Hartung, 2009]. For 
this reason, another study in our group have compared data from a clinical study 
performed by Schaumann et al., 2008 in cytokine levels after instillation of endotoxin 
with data from human PCLS exposed to LPS. The calculated coefficient of correlation 
was 0.9, indicating high resemblance and high relevance to the “human in vivo” 
situation [Schaumann et al., 2008; Switalla et al., 2010b]. Therefore, the predictive 
capacity for toxicity classification should also be more relevant after exposure to human 
PCLS with further investigations of large numbers of applied chemical substances. 
In summary, the obtained results from human PCLS could be used for studying the 
response of human lung tissue at the level of protein production, enzyme activities, and 
mediator release. Moreover, this information could be extrapolated to the human in vivo 
situation. The high degree of complexity provides a physiologically more relevant 
model for the prediction of chemical-induced toxicity in human situation which 
provides a big potential for ranking, screening and risk assessment of chemical toxicants 
[Roggen et al., 2006]. The model could not completely be used for the simple screening 
of respiratory sensitizers for the occupational asthma since the missing connection with 
the blood and lymph system. However, the neurogenic inflammation of respiratory 
epithelial cells could be used as danger signal of potential respiratory toxicants which 
could lead to asthma syndromes.  
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6 Outlook 
According to the presented data it could be shown that the multicellular microanatomy 
of PCLS provides a suitable model to assess chemical-induced acute local respiratory 
toxicity which can be used to reflect different adverse health effects and exposure 
scenarios. However, ex vivo PCLS model is limited to be used for the assessment of 
adaptive immune responses due to missing connections to the blood and lymph system. 
Early biomarkers for acute respiratory toxicity like cytokines and chemokines, 
functional changes of certain cell populations such as epithelial cell still need to be 
identified. Moreover, the use of submerged PCLS for the testing of nanomaterials and 
chemicals quickly reacting with aqueous solutions might be improved with regard to 
free contact between native atmospheres and the biological test system.  
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7 List of abbreviations 
 
3D Three-dimensional 
3Rs Refinement, reduction and replacement 
ACs Acceptance criteria 
ARDS Acute respiratory distress syndrome 
AM Calcein acetoxymethyl 
ATP Adenosine triphosphate 
BAL Bronchoalveolar lavage 
BCA Bicinchoninic acid 
B cell Bone marrow cell 
CD Cluster of differentiation 
COPD Chronic obstructive pulmonary disease 
DC  Dendritic cell 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
EC50 Effective concentration, 50% 
EthD-1 Ethidium homodimer 
GHS Globally harmonized system  
HMW High molecular weight 
IFN-γ Interferon-gamma 
IC50 Inhibitory concentration, 50% 
Ig Immunoglobulin 
IL Interleukin 
LC50 Lethal concentration, 50% 
LD50 Lethal dose, 50% 
LDH Lactate dehydrogenase 
LLNA Local lymph node assay 
LPS Lipopolysaccharide 
LMW Low molecular weight 
MCP-1 Monocyte-chemotactic protein-1 
NF-κB Nuclear factor 'kappa-light-chain-enhancer' of activated B-cells 
NK cell Natural killer cell 
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NCTC  National collection of type cultures 
OA Occupational asthma 
OECD Organization for Economic Co-operation and Development  
PAMP Pathogen-associated molecular pattern 
PRRs Pattern recognition receptors 
PBMC peripheral blood mononuclear cell 
PCLS Precision-cut lung slices  
PGEs Platinum group elements 
RADS Reactive airway dysfunction syndrome 
RANTES Regulated on activation, normally T cell expressed and secreted 
REACH Registration, evaluation, authorization and restriction of chemicals 
ROS Reactive oxygen species 
SAR Structure activity relationships 
SOPs Standard operation procedures 
T cell Thymus cell 
TH cell T helper cell 
TLR Toll-like receptor 
TG Test guideline 
TMA Trimellitic anhydride 
TNF-α Tumor necrosis factor alpha 
Tregs Regulatory T cells 
TRPA Transient receptor potential cation channel, subfamily A, member 1 
UN United Nations 
VECs Vehicle exhaust catalysts 
WST-1 Water soluble tetrazolium-1 
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